Trials / Completed
CompletedNCT05405777
A Retrospective Study to Evaluate the Clinical Outcome According to Treatment in aHUS Patients in South Korea
A Retrospective Study to Evaluate the Clinical Outcome According to Treatment in Atypical Hemolytic Uremic Syndrome (aHUS) Patients in South Korea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 97 (actual)
- Sponsor
- Handok Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Primary objective \- To determine the clinical prognosis by identifying the disease course and severity by treatment with or without eculizumab in patients with aHUS in Korea. Secondary objectives * To determine the clinical prognosis of the disease in all patients with aHUS in Korea. * To determine the clinical prognosis of the disease in patients diagnosed with aHUS prior to the initiation of eculizumab reimbursement system in Korea. * To determine the treatment responses by treatment options in patients with aHUS in Korea. * To identify risk factors that affect mortality in all patients with aHUS in Korea. * To investigate the recurrence and clinical prognosis in patients with aHUS in Korea when eculizumab is discontinued
Detailed description
As a retrospective, non-interventional, multi-center study
Conditions
Timeline
- Start date
- 2022-10-04
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2022-06-06
- Last updated
- 2025-01-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05405777. Inclusion in this directory is not an endorsement.